#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal adenocarcinoma stage III Autoimmune disorder Rheumatoid arthritis Primary mediastinal large B-cell lymphoma Paroxysmal nocturnal haemoglobinuria Primary hyperoxaluria Allogenic stem cell transplantation Hypochromic anaemia T-cell type acute leukaemia Metastatic malignant melanoma Short-bowel syndrome Cholestatic pruritus Turner's syndrome Oesophageal adenocarcinoma stage II Leukocyte adhesion deficiency type I More trials…

    Learn about Rare Diseases

    Hepatic angiosarcoma – Treatment Leukoencephalopathy – Trials in Disease Rhabdomyosarcoma – Treatment Synovial sarcoma Langerhans cell sarcoma – Treatment Angiosarcoma non-metastatic – Treatment Alagille syndrome – Diagnostics Leiomyosarcoma – Trials in Disease Systemic mastocytosis Angiosarcoma recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bulevirtide Efgartigimod Alfa Auto4 Rifapentine VANADIUM OXIDE SULFATE Ambrosia Artemisiifolia (302) ARTICAINE HYDROCHLORIDE Juniper Berry Oil Guselkumab PF-07868489 GOVORESTAT Sulfur Hexafluoride Nadunolimab Betamethasone Dipropionate Rct2100 Propranolol Hydrochloride Flortaucipir (18F) VENT-03 Eight Treg Lepidoglyphus Destructor More therapies…

    Learn about Your Condition

    Adrenoleukodystrophy Wiskott-Aldrich syndrome Cutaneous calcification Stress cardiomyopathy Toxic nodular goitre Prolymphocytic leukaemia Agitation postoperative Otitis media Breast neoplasm Sarcoma metastatic Renal cancer recurrent Axial spondyloarthritis Depression Fabry's disease Craniotomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Re-treatment with Lutetium (177Lu) Vipivotide Tetraxetan for Men with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Lutetium (177Lu) Vipivotide Tetraxetan
    • Gozetotide
    France

  • Study to Diagnose Cardiac Amyloidosis in Patients with Monoclonal Component Using Florbetaben (18F) PET-CT

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Florbetaben (18F)
    Italy

  • Study on Reducing Hospital Stay in Children with Complicated Appendicitis Using Amoxicillin and Clavulanic Acid

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amoxicillin
    • Clavulanic Acid
    Spain

  • Study on the Safety and Effectiveness of Dexamfetamine Sulfate for Adults with ADHD and Moderate to Severe Depression

    Recruiting

    2 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    • Major depression
    Investigated Drugs:
    • Dexamfetamine Sulfate
    Germany

  • Study of Epcoritamab, Lenalidomide, and Rituximab for Patients with Relapsed and Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    • Central nervous system lymphoma
    Investigated Drugs:
    • Epcoritamab
    • Lenalidomide
    • Rituximab
    France

  • Study on the Safety and Effectiveness of Belantamab Mafodotin for Adults with Primary Immune Thrombocytopenia Previously Treated with Standard Medications

    Recruiting

    2 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Belantamab Mafodotin
    Greece
Previous Page
1 … 248 249 250 251 252 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!